Ken Griffin Vivos Therapeutics, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$0.31 - $0.55 $4,092 - $7,260	-13,200 Reduced 48.35%	14,100 $7,000
Q1 2023 May 15, 2023	BUY	$0.32 - $1.88 $4,192 - $24,628	13,100 Added 92.25%	27,300 $9,000
Q4 2022 Feb 14, 2023	SELL	$0.35 - $20.75 $1,085 - $64,325	-3,100 Reduced 17.92%	14,200 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.83 - $21.25 $3,403 - $87,125	-4,100 Reduced 19.16%	17,300 $11,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.